ConforMIS Inc (NASDAQ:CFMS) stock price target upped to $13.00, reported earlier today by B. Riley
- Updated: September 15, 2016
ConforMIS Inc (NASDAQ:CFMS) had its target price bumped up to $13 by B. Riley in an issued report issued Thursday September 15 2016. The updated target price suggests a possible upside of 0.51% from the bussiness’ previous closing price.
On 5/13/2016, Deutsche Bank reported about ConforMIS Inc(NASDAQ:CFMS) lowered the target price from $26.00 to $12.00. At the time, this indicated a possible upside of 1.25%.
Only yesterday ConforMIS Inc (NASDAQ:CFMS) traded 5.26% higher at $8.60. The company’s 50-day average is $8.00 and its 200-day moving average is $8.84. With the last stock close down 2.59% relative to the 200-day average, compared to the S&P 500 Index which has decreased -0.01% over the same time. 179,044 shares of CFMS exchanged hands, down from ann average trading volume of 357,788.
With a market capitalization of $0.0, ConforMIS Inc has a 52 week low of $4.80 and a 52 week high of $23.62 with a P/E ratio of 0.
A total of 5 equity analysts have released a research note on CFMS. Three analysts rate the company a strong buy, three analysts rate the company a buy, 0 firms rate the stock a hold, 0 rate the stock to underperform, and lastly 0 firmsrate the company as sell with a consensus target of $11.20
General Company Details For ConforMIS Inc (NASDAQ:CFMS)
ConforMIS, Inc. is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee. Its iFit technology platform comprises three elements: iFit Design, iFit Printing and iFit Just-in-Time Delivery. The Company markets and sells its products in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, and Singapore and Hong Kong.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.